Capital International’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.71M Buy
27,593
+344
+1% +$123K 0.36% 76
2025
Q4
$8.92M Sell
27,249
-28,564
-51% -$9.06M 0.31% 81
2025
Q3
$15.8M Buy
55,813
+25,071
+82% +$7.27M 0.57% 50
2025
Q2
$8.58M Hold
30,742
0.33% 79
2025
Q1
$9.58M Buy
+30,742
New +$9.08M 0.42% 69

Other funds holding AMGN

Capital International's AMGN Position: Q1 2026 in Review

Capital International increased its Amgen (AMGN) stake by 1.3% in Q1 2026, buying an estimated $123K and bringing the position to 27,593 shares worth $9.71M. The position accounts for 0.36% of the portfolio, ranked #76.

Capital International first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.8M in Q3 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Capital International held 27,593 shares of Amgen worth $9.71M as of Q1 2026.
  • Capital International bought 344 Amgen shares in Q1 2026, an estimated $123K.
  • Amgen made up 0.36% of Capital International's portfolio in Q1 2026, its #76 holding.
  • Capital International first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • Capital International's Amgen position peaked at $15.8M in Q3 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Capital International's 13F filing for Q1 2026, filed 13 May 2026.